TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 41 filers reported holding TCR2 THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $42,000 | -44.7% | 15,143 | -6.6% | 0.00% | – |
| Q4 2021 | $76,000 | -46.5% | 16,210 | -2.9% | 0.00% | -100.0% |
| Q3 2021 | $142,000 | -49.3% | 16,695 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $280,000 | -24.7% | 17,092 | +1.3% | 0.00% | 0.0% |
| Q1 2021 | $372,000 | -18.6% | 16,870 | +14.2% | 0.00% | -50.0% |
| Q4 2020 | $457,000 | +47.9% | 14,768 | -2.8% | 0.00% | +100.0% |
| Q3 2020 | $309,000 | +102.0% | 15,191 | +52.5% | 0.00% | 0.0% |
| Q2 2020 | $153,000 | +183.3% | 9,962 | +43.7% | 0.00% | – |
| Q1 2020 | $54,000 | -48.6% | 6,934 | -5.5% | 0.00% | – |
| Q4 2019 | $105,000 | -5.4% | 7,335 | -0.8% | 0.00% | – |
| Q3 2019 | $111,000 | +593.8% | 7,397 | +555.2% | 0.00% | – |
| Q2 2019 | $16,000 | – | 1,129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $11,748,000 | 4.96% |
| MPM BioImpact LLC | 3,370,982 | $9,776,000 | 2.72% |
| TANG CAPITAL MANAGEMENT LLC | 3,641,606 | $10,561,000 | 1.60% |
| Newtyn Management, LLC | 692,799 | $2,009,000 | 0.38% |
| K2 PRINCIPAL FUND, L.P. | 1,078,070 | $3,126,000 | 0.34% |
| HARBOR CAPITAL ADVISORS, INC. | 64,341 | $187,000 | 0.14% |
| Redmile Group, LLC | 1,094,645 | $3,174,000 | 0.12% |
| Artal Group S.A. | 750,000 | $2,175,000 | 0.12% |
| Oasis Management Co Ltd. | 200,000 | $580,000 | 0.10% |
| X-Square Capital, LLC | 31,919 | $93,000 | 0.06% |